481,768 718,516
Net income for the period 131,559 2,298,811
Net income attributable to
noncontrolling interest (106,880) (738,855)
Net income attributable to
shareholders $24,679 $1,559,956
Net income for the period $131,559 $2,298,811
Other comprehensive income
Foreign currency translation
adjustment 64,899 1,282,528
Comprehensive income 196,458 3,581,339
Comprehensive income attributable to
noncontrolling Interest 123,043 1,009,418
Comprehensive income attributable to
shareholders $73,415 $2,571,921
Earnings per share - basic and
diluted $0.00 $0.04
Weighted average number of shares of
common stock outstanding
Basic 42,890,695 41,088,322
Diluted 42,890,695 41,470,579
SINOVAC BIOTECH LTD.
Incorporated in Antigua and Barbuda
Consolidated Statements of Cash Flows
Three months ended March 31, 2009 and 2008
Unaudited
(Expressed in U.S. Dollars)
2009 2008
Cash Flows From Operating Activities
Net income for the period $24,679 $1,559,956
Adjustments to reconcile net income to net
cash provided (used) by operating
activities:
- deferred income taxes 157,394 73,181
- gain on disposal of equipment (9,783) --
- stock-based compensation 66,503 16,636
- provision for doubtful accounts
'/>"/>SOURCE Sinovac Biotech Ltd. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Related medicine news :1.
Sinovac to Present at the Brean Murray, Carret & Co. Fourth Investor Tour of China2.
Sinovac Provides Support to Chinas Ministry of Health to Aid Earthquake Victims3.
Sinovac Announces that Government Investigation Rules Out Healives Role in Childs Death4.
New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites5.
Haemacure Reports Third Quarter 2007 Results6.
First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion7.
Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best8.
MDS Reports Third Quarter 2007 Results9.
Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 200610.
AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System11.
NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results